Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'MITCH CH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 37 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sawyer, BD; Bymaster, FP; Calligaro, DO; Falcone, J; Mitch, CH; Ward, JS; Whitesitt, C; Shannon, HE
      Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta

      GENERAL PHARMACOLOGY
    2. Bymaster, FP; Shannon, HE; Rasmussen, K; DeLapp, NW; Ward, JS; Calligaro, DO; Mitch, CH; Whitesitt, C; Ludvigsen, TS; Sheardown, M; Swedberg, M; Rasmussen, T; Olesen, PH; Jeppesen, L; Sauerberg, P; Fink-Jensen, A
      Potential role of muscarinic receptors in schizophrenia

      LIFE SCIENCES
    3. Shannon, HE; Hart, JC; Bymaster, FP; Calligaro, DO; Delapp, NW; Mitch, CH; Ward, JS; Fink-Jensen, A; Sauerberg, P; Jeppesen, L; Sheardown, MJ; Swedberg, MDB
      Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; MITCH CH; WHITESITT C; BRUNSTING D; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; JEPPESEN L; SAUERBERG P
      1,2,5-THIADIAZOLE ANALOGS OF ACECLIDINE AS POTENT M(1) MUSCARINIC AGONISTS

      Journal of medicinal chemistry
    5. BYMASTER FP; SHANNON HE; RASMUSSEN K; DELAPP NW; MITCH CH; WARD JS; CALLIGARO DO; LUDVIGSEN TS; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; SAUERBERG P; FINKJENSEN A
      UNEXPECTED ANTIPSYCHOTIC-LIKE ACTIVITY WITH THE MUSCARINIC RECEPTOR-LIGAND O-1,2,5-THIADIAZOL-4-YL)-1-AZABICYCLO[3.2.1]OCTANE

      European journal of pharmacology
    6. BYMASTER FP; CARTER PA; PETERS SC; ZHANG W; WARD JS; MITCH CH; CALLIGARO DO; WHITESITT CA; DELAPP N; SHANNON HE; RIMVALL K; JEPPESEN L; SHEARDOWN MJ; FINKJENSEN A; SAUERBERG P
      XANOMELINE COMPARED TO OTHER MUSCARINIC AGENTS ON STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO AND OTHER CHOLINOMIMETIC EFFECTS

      Brain research
    7. OLESEN PH; SAUERBERG P; PETERSEN TG; TREPPENDAHL S; BENTZEN B; DEETER J; WARD JS; MITCH CH; LEHMANN SNV
      SYNTHESIS AND STRUCTURAL DETERMINATION OF STEREOISOMERS OF MUSCARINICLIGANDS OF THE OPYLTHIO-1,2,5-THIADIAZOL-4-YL)-1-AZABICYCLOALKANE TYPE

      Chirality
    8. BYMASTER FP; WHITESITT CA; SHANNON HE; DELAPP N; WARD JS; CALLIGARO DO; SHIPLEY LA; BUELKESAM JL; BODICK NC; FARDE L; SHEARDOWN MJ; OLESEN PH; HANSEN KT; SUZDAK PD; SWEDBERG MDB; SAUERBERG P; MITCH CH
      XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Drug development research
    9. SAUERBERG P; OLESEN PH; THOGERSEN H; NIELSEN S; SHEARDOWN MJ; RIMVALL K; SHANNON HE; WARD JS; MITCH CH; BYMASTER FP; SWEDBERG MDB
      CONFORMATIONALLY CONSTRAINED ANALOGS OF THE MUSCARINIC AGONIST METHYLTHIO-TZTP - SYNTHESIS, RECEPTOR AFFINITY AND ANALGESIC ACTIVITY

      Life sciences
    10. WARD JS; MERRITT L; STRATFORD R; BROWN TJ; WIJAYARATNE R; SZEWCZYK SP; CALLIGARO DO; BYMASTER FP; SHANNON HE; MITCH CH; JOHNSON DW; WIKEL JH; OLESEN MJ; SHEARDOWN MJ; SWEDBERG MDB; SAUERBERG P
      THE TETRAHYDROPYRIDINE RING CONFERS OPTIMAL M(1) SELECTIVITY AND BLOOD-BRAIN-BARRIER PENETRATION AMONG HEXYLOXY-1,2,5-THIADIAZOLE AZACYCLES

      Life sciences
    11. SHANNON HE; WOMER DE; DELAPP NW; BYMASTER FP; MITCH CH; WARD JS; WHITESITT C; CALLIGARO D; SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; RIMVALL K; FINKJENSEN A; JEPPESEN L
      MUSCARINIC AGONISTS PRODUCE ANALGESIA THROUGH PERTUSSIS-TOXIN-SENSITIVE MUSCARINIC RECEPTORS IN THE SPINAL-CORD

      Life sciences
    12. SWEDBERG MDB; SHANNON HE; SHEARDOWN MJ; KLITGAARD H; BYMASTER FP; WARD JS; MITCH CH; OLESEN PH; ESKESEN K; SUZDAK PD; CALLIGARO DO; SAUERBERG P
      ANTICONVULSANT EFFECTS OF MUSCARINICS

      Life sciences
    13. SHANNON HE; WOMER DE; BYMASTER FP; CALLIGARO DO; DELAPP NC; MITCH CH; WARD JS; WHITESITT CA; SWEDBERG MDB; SHEARDOWN MJ; FINKJENSEN A; OLESEN PH; RIMVALL K; SAUERBERG P
      IN-VIVO PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053), AN ORALLY ACTING ANTINOCICEPTIVE MUSCARINIC AGONIST/

      Life sciences
    14. SHEARDOWN MJ; SHANNON HE; SWEDBERG MDB; SUZDAK PD; BYMASTER FP; OLESEN PH; MITCH CH; WARD JS; SAUERBERG P
      M-1 RECEPTOR AGONIST ACTIVITY IS NOT A REQUIREMENT FOR MUSCARINIC ANTINOCICEPTION

      The Journal of pharmacology and experimental therapeutics
    15. SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; OLESEN PH; SUZDAK PD; HANSEN KT; BYMASTER FP; WARD JS; MITCH CH; CALLIGARO DO; DELAPP NW; SHANNON HE
      BUTYLTHIO[2.2.2] (NNC 11-1053 LY297802) - AN ORALLY-ACTIVE MUSCARINICAGONIST ANALGESIC/

      The Journal of pharmacology and experimental therapeutics
    16. SHANNON HE; SHEARDOWN MJ; BYMASTER FP; CALLIGARO DO; DELAPP NW; GIDDA J; MITCH CH; SAWYER BD; STENGEL PW; WARD JS; WONG DT; OLESEN PH; SUZDAK PD; SAUERBERG P; SWEDBERG MDB
      PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053) - A NOVEL ANALGESIC WITH MIXED MUSCARINIC RECEPTOR AGONIST AND ANTAGONIST ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    17. MITCH CH; BROWN TJ; BYMASTER FP; CALLIGARO DO; DIECKMAN D; MERRIT L; PETERS SC; QUIMBY SJ; SHANNON HE; SHIPLEY LA; WARD JS; HANSEN K; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SWEDBERG MDB; SUZDAK P; GREENWOOD B
      MUSCARINIC ANALGESICS WITH POTENT AND SELECTIVE EFFECTS ON THE GASTROINTESTINAL-TRACT - POTENTIAL APPLICATION FOR THE TREATMENT OF IRRITABLE-BOWEL-SYNDROME

      Journal of medicinal chemistry
    18. OLESEN PH; SAUERBERG P; TREPPENDAHL S; LARSSON O; SHEARDOWN MJ; SUZDAK PD; MITCH CH; WARD JS; BYMASTER FP; SHANNON HE; SWEDBERG MDB
      3-(3-ALKYLTHIO-1,2,5-THIADIAZOL-4-YL)1-AZABICYCLE - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR ANTINOCICEPTION MEDIATED BY CENTRAL MUSCARINIC RECEPTORS

      European journal of medicinal chemistry
    19. ECKOLS K; BYMASTER FP; MITCH CH; SHANNON HE; WARD JS; DELAPP NW
      THE MUSCARINIC M1 AGONIST XANOMELINE INCREASES SOLUBLE AMYLOID PRECURSOR PROTEIN RELEASE FROM CHINESE-HAMSTER OVARY-M1 CELLS

      Life sciences
    20. SAUERBERG P; OLESEN PH; SHEARDOWN MJ; SUZDAK PD; SHANNON HE; BYMASTER FP; CALLIGARO DO; MITCH CH; WARD JS; SWEDBERG MDB
      MUSCARINIC AGONISTS AS ANALGESICS - ANTINOCICEPTIVE ACTIVITY VERSUS M(1) ACTIVITY - SAR OF ALKYLTHIO-TZTPS AND RELATED 1,2,5-THIADIAZOLE ANALOGS

      Life sciences
    21. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; SAWYER BD; MITCH CH; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB
      3-(3-HEXYLOXYPYRAZINYL) QUINUCLIDINE AS A FUNCTIONALLY SELECTIVE M(1)AGONIST

      Life sciences
    22. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SAWYER BD; WARD JS; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SUZDAK PD; SWEDBERG M; SHANNON HE
      SIDE-CHAIN STERIC BULK AND MUSCARINIC AGONIST SAR IN ALKOXY-TZTPS

      Life sciences
    23. SAWYER BD; SHANNON HE; WARD JS; MITCH CH; SHEARDOWN MJ; OLESEN PH; SAUERBERG P
      MUSCARINIC RECEPTOR CHARACTERIZATION AND EVALUATION OF A SERIES OF NOVEL MUSCARINIC LIGANDS IN THE ISOLATED RABBIT THORACIC AORTA

      Life sciences
    24. DELAPP NW; ECKOLS K; BYMASTER FP; MITCH CH; SHANNON HE; WARD JS
      THE M1 AGONIST XANOMELINE POTENTLY STIMULATES APPS RELEASE FROM CHO-M1 CELLS

      Life sciences
    25. SHANNON HE; BYMASTER FP; CALLIGARO DO; MITCH CH; SAWYER BD; WARD JS; SHEARDOWN MJ; OLESEN PH; SAUERBERG P; SUZDAK PD; SWEDBERG MDB
      IN-VITRO PHARMACOLOGY OF THE MUSCARINIC ANALGESIC LY297802 NNC111053/

      Life sciences
    26. SWEDBERG MDB; SHEARDOWN MJ; SAUERBERG P; OLESEN P; SUZDAK PD; BYMASTER FP; WARD JS; MITCH CH; CALLIGARO DO; SHANNON HE
      NNC-11-1053 LY-297802 - AN ANTINOCICEPTIVE ORALLY ACTING MUSCARINIC AGONIST IN MOUSE AND RAT

      Life sciences
    27. WARD JS; MERRITT L; CALLIGARO DO; BYMASTER FP; SHANNON HE; SAWYER BD; MITCH CH; DEETER JB; PETERS SC; SHEARDOWN MJ; OLESEN PH; SWEDBERG MDB; SAUERBERG P
      FUNCTIONALLY SELECTIVE M(1) MUSCARINIC AGONISTS .3. SIDE-CHAINS AND AZACYCLES CONTRIBUTING TO FUNCTIONAL MUSCARINIC SELECTIVITY AMONG PYRAZINYLAZACYCLES

      Journal of medicinal chemistry
    28. SHANNON HE; BYMASTER FP; HENDRIX JC; QUIMBY SJ; MITCH CH
      NOVEL ALKOXY-OXAZOLYL-TETRAHYDROPYRIDINE MUSCARINIC CHOLINERGIC RECEPTOR ANTAGONISTS

      Psychopharmacology
    29. COHEN ML; MENDELSOHN LG; MITCH CH; ZIMMERMAN DM
      USE OF THE MOUSE VAS-DEFERENS TO DETERMINE MU-RECEPTOR, DELTA-RECEPTOR, AND KAPPA-RECEPTOR AFFINITIES OF OPIOID ANTAGONISTS

      Receptor
    30. QUIMBY SJ; SHANNON HE; BYMASTER FP; SAUERBERG P; OLESEN PH; SHEARDOWN MJ; SUZDAK PD; MITCH CH
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF ALKYL SUBSTITUTED ANALOGS OF THE FUNCTIONAL M(1) SELECTIVE MUSCARINIC RECEPTOR AGONIST XANOMELINE

      Bioorganic & medicinal chemistry letters
    31. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SCHOEPP DD; WONG DT; SHANNON HE
      MUSCARINIC ANTAGONIST ACTIVITY OF (5-ALKOXY-OXAZOL-2-YL)-1,2,5,6-TETRAHYDROPYRIDINES

      Bioorganic & medicinal chemistry letters
    32. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SAWYER BD; SHANNON HE; WARD JS; OLESEN PH; SAUERBERG P; SHEARDOWN MJ; SUZDAK PD
      XANOMELINE - A POTENT AND SELECTIVE M1 MUSCARINIC AGONIST IN-VITRO

      Neurobiology of aging
    33. SHANNON HE; BYMASTER FP; CALLIGARO DO; GREENWOOD B; MITCH CH; SAWYER BD; WARD JS; WONG DT; OLESEN PH; SHEARDOWN MJ; SWEDBERG MDB; SUZDAK PD; SAUERBERG P
      XANOMELINE - A NOVEL MUSCARINIC RECEPTOR AGONIST WITH FUNCTIONAL SELECTIVITY FOR M(1) RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    34. BYMASTER FP; WONG DT; MITCH CH; WARD JS; CALLIGARO DO; SCHOEPP DD; SHANNON HE; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB; SAUERBERG P
      NEUROCHEMICAL EFFECTS OF THE M(1) MUSCARINIC AGONIST XANOMELINE (LY246708 NNC11-0232)/

      The Journal of pharmacology and experimental therapeutics
    35. HEMRICKLUECKE SK; MITCH CH; QUIMBY SJ; FULLER RW
      EFFECT OF ADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE, AN ANALOG OF MPTP, ON MOUSE HEART NOREPINEPHRINE AND BRAIN CATECHOLAMINES

      Neurochemistry international
    36. ZIMMERMAN DM; LEANDER JD; CANTRELL BE; REEL JK; SNODDY J; MENDELSOHN LG; JOHNSON BG; MITCH CH
      STRUCTURE-ACTIVITY-RELATIONSHIPS OF TRANS-3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE ANTAGONISTS FOR MU-OPIOID AND KAPPA-OPIOID RECEPTORS

      Journal of medicinal chemistry
    37. MITCH CH; LEANDER JD; MENDELSOHN LG; SHAW WN; WONG DT; CANTRELL BE; JOHNSON BG; REEL JK; SNODDY JD; TAKEMORI AE; ZIMMERMAN DM
      3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINES - OPIOID ANTAGONISTS WITHPOTENT ANORECTANT ACTIVITY

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 05:13:51